Insulin infusion sets worn for more than 4-5 days have been associated with a greater risk of unexplained hyperglycemia, a phenomenon that has been hypothesized to be caused by an inflammatory response to preservatives such as m-cresol and phenol. In this cross-over study in diabetic swine, we examined the role of the preservative m-cresol in inflammation and changes in infusion site patency. Insulin pharmacokinetics (PK) and glucose pharmacodynamics (PD) were measured on delivery of a bolus of regular human insulin U-100 (U-100R), formulated with or without 2.5 mg/mL m-cresol, to fasted swine following 0, 3, 5, 7, and 10 days of continuous subcutaneous insulin infusion (CSII). In a subsequent study with the same animals, biopsies were evaluated from swine wearing infusion sets infusing nothing, saline, or U-100R either with or without 2.5 mg/mL m-cresol, following 3, 7, and 10 days of CSII. Exposure to m-cresol did not impact any PK or PD endpoints. PK and PD responses dropped markedly from Days 7-10, regardless of the presence of m-cresol. Histopathology results suggest an additive inflammatory response to both the infusion set and the insulin protein itself, peaking at Day 7 and remaining stable beyond.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.xphs.2020.12.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interaction of preservatives with contact materials during filling and storage of parenteral liquid formulations.
Eur J Pharm Sci
January 2025
Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG 88400 Biberach, Germany.
Silicone tubing is a frequently used material in pharmaceutical filling processes for parenteral formulations, as its characteristics like flexibility, chemical resistance and easy handling make it particularly suitable for these purposes. This study investigated the time-dependent interaction of phenol and m-cresol with silicone tubing and other broadly applied contact materials used during the filling and transport processes of parenteral formulations. Phenol losses could be observed after incubation in silicone tubing, depending on the inner diameter (ID).
View Article and Find Full Text PDFA Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.
Vaccines (Basel)
May 2024
Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA.
Article Synopsis
- During the development of recombinant vaccines, protein antigens can be destabilized by antimicrobial preservatives (APs), complicating understanding and analysis of their degradation.
- This study evaluates various analytical methods, specifically looking at HPV16 VLPs with different preservatives under accelerated conditions to assess structural integrity.
- The findings highlight that alternative approaches, like competitive ELISA and LC-MS peptide mapping, offer better insights into the molecular mechanisms of AP-induced destabilization compared to traditional methods.
Interaction between preservatives and a monoclonal antibody in support of multidose formulation development.
Int J Pharm
December 2023
Department of Chemistry, The University of Kansas, Lawrence KS, USA. Electronic address:
Multidose formulations have patient-centric advantages over single-dose formats. A major challenge in developing multidose formulations is the prevention of microbial growth that can potentially be introduced during multiple drawings. The incorporation of antimicrobial preservatives (APs) is a common approach to inhibit this microbial growth.
View Article and Find Full Text PDFRefrigerated multi-dose insulin vials remain sterile through 6 months of use.
J Small Anim Pract
December 2023
North Carolina State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA.
Objectives: To evaluate sterility in refrigerated multi-dose insulin vials through 6 months of routine aspiration.
Materials And Methods: Twelve vials of insulin, six of insulin glargine U100 (Lantus®, 10 mL multi-dose vial, Sanofi, Bridgewater, NJ) containing the preservative metacresol, and six of protamine zinc insulin U40 (ProZinc®, 10 mL multi-dose vial, Boehringer Ingelheim, Duluth, GA) containing the preservative phenol, were refrigerated and aspirated twice daily for 6 months, using a new insulin syringe each time. Three vials of each insulin type were wiped with a single-use alcohol swab before sampling.
Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview.
Pharmaceutics
February 2023
Innovation Unit, PDB-TIP, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach an der Riss, Germany.
Biological drugs intended for multi-dose application require the presence of antimicrobial preservatives to avoid microbial growth. As the presence of certain preservatives has been reported to increase protein and peptide particle formation, it is essential to choose a preservative compatible with the active pharmaceutical ingredient in addition to its preservation function. Thus, this review describes the current status of the use of antimicrobial preservatives in biologic formulations considering (i) appropriate preservatives for protein and peptide formulations, (ii) their physico-chemical properties, (iii) their in-/compatibilities with other excipients or packaging material, and (iv) their interactions with the biological compound.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!